Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 182

    1.

    Inhibition of neuraminidase inhibitor-resistant influenza virus by DAS181, a novel sialidase fusion protein.

    Triana-Baltzer GB, Gubareva LV, Klimov AI, Wurtman DF, Moss RB, Hedlund M, Larson JL, Belshe RB, Fang F.

    PLoS One. 2009 Nov 6;4(11):e7838.PMID: 19893749 [PubMed - in process]Related articlesFree article

    2.

    Implications of the emergence of a novel H1 influenza virus.

    Belshe RB.

    N Engl J Med. 2009 Jun 18;360(25):2667-8. Epub 2009 May 7. No abstract available. PMID: 19423870 [PubMed - indexed for MEDLINE]Related articles

    3.

    Evaluation of smallpox vaccines using variola neutralization.

    Damon IK, Davidson WB, Hughes CM, Olson VA, Smith SK, Holman RC, Frey SE, Newman F, Belshe RB, Yan L, Karem K.

    J Gen Virol. 2009 Aug;90(Pt 8):1962-6. Epub 2009 Apr 1.PMID: 19339477 [PubMed - indexed for MEDLINE]Related articles

    4.

    An introduction to influenza: lessons from the past in epidemiology, prevention, and treatment.

    Belshe RB.

    Manag Care. 2008 Oct;17(10 Suppl 10):2-7.PMID: 19025131 [PubMed - indexed for MEDLINE]Related articles

    5.

    Safety and efficacy of live attenuated influenza vaccine in children 2-7 years of age.

    Belshe RB, Ambrose CS, Yi T.

    Vaccine. 2008 Sep 12;26 Suppl 4:D10-6.PMID: 18611422 [PubMed - indexed for MEDLINE]Related articles

    6.

    Cost-effectiveness of live attenuated influenza vaccine versus inactivated influenza vaccine among children aged 24-59 months in the United States.

    Luce BR, Nichol KL, Belshe RB, Frick KD, Li SX, Boscoe A, Rousculp MD, Mahadevia PJ.

    Vaccine. 2008 Jun 2;26(23):2841-8. Epub 2008 May 6.PMID: 18462851 [PubMed - indexed for MEDLINE]Related articles

    7.

    Clinical and immunologic responses to multiple doses of IMVAMUNE (Modified Vaccinia Ankara) followed by Dryvax challenge.

    Frey SE, Newman FK, Kennedy JS, Sobek V, Ennis FA, Hill H, Yan LK, Chaplin P, Vollmar J, Chaitman BR, Belshe RB.

    Vaccine. 2007 Dec 12;25(51):8562-73. Epub 2007 Oct 26.PMID: 18036708 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Translational research on vaccines: influenza as an example.

    Belshe RB.

    Clin Pharmacol Ther. 2007 Dec;82(6):745-9. Epub 2007 Oct 31. Review.PMID: 17971813 [PubMed - indexed for MEDLINE]Related articles

    9.

    The burden of influenza and strategies for prevention.

    Belshe RB.

    Manag Care. 2007 Aug;16(8 Suppl 8):2-6; discussion 17-9. No abstract available. PMID: 17927016 [PubMed - indexed for MEDLINE]Related articles

    10.

    The absence of enhanced disease with wild type respiratory syncytial virus infection occurring after receipt of live, attenuated, respiratory syncytial virus vaccines.

    Wright PF, Karron RA, Belshe RB, Shi JR, Randolph VB, Collins PL, O'Shea AF, Gruber WC, Murphy BR.

    Vaccine. 2007 Oct 16;25(42):7372-8. Epub 2007 Aug 28.PMID: 17868959 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Comparative immunogenicity of trivalent influenza vaccine administered by intradermal or intramuscular route in healthy adults.

    Belshe RB, Newman FK, Wilkins K, Graham IL, Babusis E, Ewell M, Frey SE.

    Vaccine. 2007 Sep 17;25(37-38):6755-63. Epub 2007 Jul 26.PMID: 17692438 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Antibody responses to vaccinia membrane proteins after smallpox vaccination.

    Lawrence SJ, Lottenbach KR, Newman FK, Buller RM, Bellone CJ, Chen JJ, Cohen GH, Eisenberg RJ, Belshe RB, Stanley SL Jr, Frey SE.

    J Infect Dis. 2007 Jul 15;196(2):220-9. Epub 2007 Jun 4.PMID: 17570109 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    The immunogenetics of smallpox vaccination.

    Stanley SL Jr, Frey SE, Taillon-Miller P, Guo J, Miller RD, Koboldt DC, Elashoff M, Christensen R, Saccone NL, Belshe RB.

    J Infect Dis. 2007 Jul 15;196(2):212-9. Epub 2007 Jun 4.PMID: 17570108 [PubMed - indexed for MEDLINE]Related articles

    14.

    Comparison of results of detection of rhinovirus by PCR and viral culture in human nasal wash specimens from subjects with and without clinical symptoms of respiratory illness.

    Wright PF, Deatly AM, Karron RA, Belshe RB, Shi JR, Gruber WC, Zhu Y, Randolph VB.

    J Clin Microbiol. 2007 Jul;45(7):2126-9. Epub 2007 May 2.PMID: 17475758 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Prevaccine determination of the expression of costimulatory B7 molecules in activated monocytes predicts influenza vaccine responses in young and older adults.

    van Duin D, Allore HG, Mohanty S, Ginter S, Newman FK, Belshe RB, Medzhitov R, Shaw AC.

    J Infect Dis. 2007 Jun 1;195(11):1590-7. Epub 2007 Apr 17.PMID: 17471428 [PubMed - indexed for MEDLINE]Related articles

    16.

    Live attenuated versus inactivated influenza vaccine in infants and young children.

    Belshe RB, Edwards KM, Vesikari T, Black SV, Walker RE, Hultquist M, Kemble G, Connor EM; CAIV-T Comparative Efficacy Study Group.

    N Engl J Med. 2007 Feb 15;356(7):685-96. Erratum in: N Engl J Med. 2007 Mar 22;356(12):1283. PMID: 17301299 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Transmissibility, infectivity and immunogenicity of a live human parainfluenza type 3 virus vaccine (HPIV3cp45) among susceptible infants and toddlers.

    Madhi SA, Cutland C, Zhu Y, Hackell JG, Newman F, Blackburn N, Murphy BR, Belshe RB, Karron RA, Deatly AM, Gruber WC, Bernstein DI, Wright PF.

    Vaccine. 2006 Mar 20;24(13):2432-9. Epub 2005 Dec 20.PMID: 16406170 [PubMed - indexed for MEDLINE]Related articles

    18.

    The origins of pandemic influenza--lessons from the 1918 virus.

    Belshe RB.

    N Engl J Med. 2005 Nov 24;353(21):2209-11. No abstract available. PMID: 16306515 [PubMed - indexed for MEDLINE]Related articles

    19.

    Flow-cytometric detection of vaccinia-induced memory effector CD4(+), CD8(+), and gamma delta TCR(+) T cells capable of antigen-specific expansion and effector functions.

    Abate G, Eslick J, Newman FK, Frey SE, Belshe RB, Monath TP, Hoft DF.

    J Infect Dis. 2005 Oct 15;192(8):1362-71. Epub 2005 Sep 8.PMID: 16170753 [PubMed - indexed for MEDLINE]Related articles

    20.

    Identification of a recombinant live attenuated respiratory syncytial virus vaccine candidate that is highly attenuated in infants.

    Karron RA, Wright PF, Belshe RB, Thumar B, Casey R, Newman F, Polack FP, Randolph VB, Deatly A, Hackell J, Gruber W, Murphy BR, Collins PL.

    J Infect Dis. 2005 Apr 1;191(7):1093-104. Epub 2005 Mar 1.PMID: 15747245 [PubMed - indexed for MEDLINE]Related articles

    21.

    The genetic archaeology of influenza.

    Hoft DF, Belshe RB.

    N Engl J Med. 2004 Dec 9;351(24):2550-1. No abstract available. PMID: 15590961 [PubMed - indexed for MEDLINE]Related articles

    22.

    Evaluation of combined live, attenuated respiratory syncytial virus and parainfluenza 3 virus vaccines in infants and young children.

    Belshe RB, Newman FK, Anderson EL, Wright PF, Karron RA, Tollefson S, Henderson FW, Meissner HC, Madhi S, Roberton D, Marshall H, Loh R, Sly P, Murphy B, Tatem JM, Randolph V, Hackell J, Gruber W, Tsai TF.

    J Infect Dis. 2004 Dec 15;190(12):2096-103. Epub 2004 Nov 8.PMID: 15551207 [PubMed - indexed for MEDLINE]Related articles

    23.

    Serum antibody responses after intradermal vaccination against influenza.

    Belshe RB, Newman FK, Cannon J, Duane C, Treanor J, Van Hoecke C, Howe BJ, Dubin G.

    N Engl J Med. 2004 Nov 25;351(22):2286-94. Epub 2004 Nov 3.PMID: 15525713 [PubMed - indexed for MEDLINE]Related articlesFree article

    24.

    Safety, efficacy, and effectiveness of live, attenuated, cold-adapted influenza vaccine in an indicated population aged 5-49 years.

    Belshe RB, Nichol KL, Black SB, Shinefield H, Cordova J, Walker R, Hessel C, Cho I, Mendelman PM.

    Clin Infect Dis. 2004 Oct 1;39(7):920-7. Epub 2004 Sep 7.PMID: 15472840 [PubMed - indexed for MEDLINE]Related articles

    25.

    Induction of human T cell-mediated immune responses after primary and secondary smallpox vaccination.

    Kennedy JS, Frey SE, Yan L, Rothman AL, Cruz J, Newman FK, Orphin L, Belshe RB, Ennis FA.

    J Infect Dis. 2004 Oct 1;190(7):1286-94. Epub 2004 Aug 30.PMID: 15346340 [PubMed - indexed for MEDLINE]Related articles

    26.

    Breakthrough infections during phase 1 and 2 prime-boost HIV-1 vaccine trials with canarypox vectors (ALVAC) and booster dose of recombinant gp120 or gp160.

    Lee D, Graham BS, Chiu YL, Gilbert PB, McElrath MJ, Belshe RB, Buchbinder SP, Sheppard HW, Koblin BA, Mayer KH, Keefer MC, Mulligan MJ, Celum CL.

    J Infect Dis. 2004 Sep 1;190(5):903-7. Epub 2004 Jul 29.PMID: 15295694 [PubMed - indexed for MEDLINE]Related articles

    27.

    Current status of live attenuated influenza virus vaccine in the US.

    Belshe RB.

    Virus Res. 2004 Jul;103(1-2):177-85. Review.PMID: 15163507 [PubMed - indexed for MEDLINE]Related articles

    28.

    Safety and efficacy of trivalent inactivated influenza vaccine in young children: a summary for the new era of routine vaccination.

    Zangwill KM, Belshe RB.

    Pediatr Infect Dis J. 2004 Mar;23(3):189-97. Review.PMID: 15014289 [PubMed - indexed for MEDLINE]Related articles

    29.

    Safety and efficacy of live attenuated, cold-adapted, influenza vaccine-trivalent.

    Belshe RB, Mendelman PM.

    Immunol Allergy Clin North Am. 2003 Nov;23(4):745-67. Review.PMID: 14753390 [PubMed - indexed for MEDLINE]Related articles

    30.

    Dose-dependent neutralizing-antibody responses to vaccinia.

    Belshe RB, Newman FK, Frey SE, Couch RB, Treanor JJ, Tacket CO, Yan L.

    J Infect Dis. 2004 Feb 1;189(3):493-7. Epub 2004 Jan 23.PMID: 14745707 [PubMed - indexed for MEDLINE]Related articles

    31.

    Phase 2 evaluation of parainfluenza type 3 cold passage mutant 45 live attenuated vaccine in healthy children 6-18 months old.

    Belshe RB, Newman FK, Tsai TF, Karron RA, Reisinger K, Roberton D, Marshall H, Schwartz R, King J, Henderson FW, Rodriguez W, Severs JM, Wright PF, Keyserling H, Weinberg GA, Bromberg K, Loh R, Sly P, McIntyre P, Ziegler JB, Hackell J, Deatly A, Georgiu A, Paschalis M, Wu SL, Tatem JM, Murphy B, Anderson E.

    J Infect Dis. 2004 Feb 1;189(3):462-70. Epub 2004 Jan 20.PMID: 14745704 [PubMed - indexed for MEDLINE]Related articles

    32.

    Poxvirus zoonoses--putting pocks into context.

    Frey SE, Belshe RB.

    N Engl J Med. 2004 Jan 22;350(4):324-7. No abstract available. PMID: 14736922 [PubMed - indexed for MEDLINE]Related articles

    33.

    Binding of antibodies to human immunodeficiency virus type 1 (HIV-1)-infected lymphocytes elicited by vaccines and by natural infection.

    Gorse GJ, Patel GB, Arbuckle JA, Belshe RB.

    Vaccine. 2004 Jan 2;22(3-4):383-97.PMID: 14670320 [PubMed - indexed for MEDLINE]Related articles

    34.

    Improved assay to detect neutralizing antibody following vaccination with diluted or undiluted vaccinia (Dryvax) vaccine.

    Newman FK, Frey SE, Blevins TP, Mandava M, Bonifacio A Jr, Yan L, Belshe RB.

    J Clin Microbiol. 2003 Jul;41(7):3154-7.PMID: 12843056 [PubMed - indexed for MEDLINE]Related articlesFree article

    35.

    Response to smallpox vaccine in persons immunized in the distant past.

    Frey SE, Newman FK, Yan L, Lottenbach KR, Belshe RB.

    JAMA. 2003 Jun 25;289(24):3295-9. Erratum in: JAMA. 2003 Jul 16;290(3):334. PMID: 12824212 [PubMed - indexed for MEDLINE]Related articlesFree article

    36.

    A live human parainfluenza type 3 virus vaccine is attenuated and immunogenic in young infants.

    Karron RA, Belshe RB, Wright PF, Thumar B, Burns B, Newman F, Cannon JC, Thompson J, Tsai T, Paschalis M, Wu SL, Mitcho Y, Hackell J, Murphy BR, Tatem JM.

    Pediatr Infect Dis J. 2003 May;22(5):394-405.PMID: 12792378 [PubMed - indexed for MEDLINE]Related articles

    37.

    Stability of undiluted and diluted vaccinia-virus vaccine, Dryvax.

    Newman FK, Frey SE, Blevins TP, Yan L, Belshe RB.

    J Infect Dis. 2003 Apr 15;187(8):1319-22. Epub 2003 Apr 2.PMID: 12696013 [PubMed - indexed for MEDLINE]Related articles

    38.

    Safety of the trivalent, cold-adapted influenza vaccine in preschool-aged children.

    Piedra PA, Yan L, Kotloff K, Zangwill K, Bernstein DI, King J, Treanor J, Munoz F, Wolff M, Cho I, Mendelman PM, Cordova J, Belshe RB.

    Pediatrics. 2002 Oct;110(4):662-72.PMID: 12359778 [PubMed - indexed for MEDLINE]Related articlesFree article

    39.

    Live attenuated intranasal influenza vaccine.

    Belshe RB, Couch RB, Glezen WP, Treanor JT.

    Vaccine. 2002 Oct 4;20(29-30):3429-30. No abstract available. PMID: 12297386 [PubMed - indexed for MEDLINE]Related articles

    40.

    Clinical responses to undiluted and diluted smallpox vaccine.

    Frey SE, Couch RB, Tacket CO, Treanor JJ, Wolff M, Newman FK, Atmar RL, Edelman R, Nolan CM, Belshe RB; National Institute of Allergy and Infectious Diseases Smallpox Vaccine Study Group.

    N Engl J Med. 2002 Apr 25;346(17):1265-74. Epub 2002 Mar 28.PMID: 11923490 [PubMed - indexed for MEDLINE]Related articlesFree article

    41.

    Dose-related effects of smallpox vaccine.

    Frey SE, Newman FK, Cruz J, Shelton WB, Tennant JM, Polach T, Rothman AL, Kennedy JS, Wolff M, Belshe RB, Ennis FA.

    N Engl J Med. 2002 Apr 25;346(17):1275-80. Epub 2002 Mar 28.PMID: 11923489 [PubMed - indexed for MEDLINE]Related articlesFree article

    42.

    Safety, efficacy and effectiveness of cold-adapted, live, attenuated, trivalent, intranasal influenza vaccine in adults and children.

    Belshe RB, Gruber WC.

    Philos Trans R Soc Lond B Biol Sci. 2001 Dec 29;356(1416):1947-51.PMID: 11779396 [PubMed - indexed for MEDLINE]Related articlesFree article

    43.

    Safety, vaccine virus shedding and immunogenicity of trivalent, cold-adapted, live attenuated influenza vaccine administered to human immunodeficiency virus-infected and noninfected children.

    King JC Jr, Fast PE, Zangwill KM, Weinberg GA, Wolff M, Yan L, Newman F, Belshe RB, Kovacs A, Deville JG, Jelonek M; HIV Influenza Study Group.

    Pediatr Infect Dis J. 2001 Dec;20(12):1124-31.PMID: 11740317 [PubMed - indexed for MEDLINE]Related articles

    44.

    HIV type 1 vaccine-induced T cell memory and cytotoxic T lymphocyte responses in HIV type 1-uninfected volunteers.

    Gorse GJ, Patel GB, Belshe RB; National Institute of Allergy and Infectious Diseases HIV Vaccine Trials Network.

    AIDS Res Hum Retroviruses. 2001 Aug 10;17(12):1175-89.PMID: 11522187 [PubMed - indexed for MEDLINE]Related articles

    45.

    Cost-effectiveness analysis of an intranasal influenza vaccine for the prevention of influenza in healthy children.

    Luce BR, Zangwill KM, Palmer CS, Mendelman PM, Yan L, Wolff MC, Cho I, Marcy SM, Iacuzio D, Belshe RB.

    Pediatrics. 2001 Aug;108(2):E24.PMID: 11483834 [PubMed - indexed for MEDLINE]Related articlesFree article

    46.

    Canarypox vaccines induce antigen-specific human gammadelta T cells capable of interferon-gamma production.

    Worku S, Gorse GJ, Belshe RB, Hoft DF.

    J Infect Dis. 2001 Sep 1;184(5):525-32. Epub 2001 Jul 26.PMID: 11474428 [PubMed - indexed for MEDLINE]Related articles

    47.

    Immunoregulatory role of secreted glycoprotein G from respiratory syncytial virus.

    Ray R, Hoft DF, Meyer K, Brown R, Lagging LM, Belshe RB.

    Virus Res. 2001 Jun;75(2):147-54.PMID: 11325469 [PubMed - indexed for MEDLINE]Related articles

    48.

    Safety and immunogenicity of a canarypox-vectored human immunodeficiency virus Type 1 vaccine with or without gp120: a phase 2 study in higher- and lower-risk volunteers.

    Belshe RB, Stevens C, Gorse GJ, Buchbinder S, Weinhold K, Sheppard H, Stablein D, Self S, McNamara J, Frey S, Flores J, Excler JL, Klein M, Habib RE, Duliege AM, Harro C, Corey L, Keefer M, Mulligan M, Wright P, Celum C, Judson F, Mayer K, McKirnan D, Marmor M, Woody G; National Institute of Allergy and Infectious Diseases AIDS Vaccine Evaluation Group and HIV Network for Prevention Trials (HIVNET).

    J Infect Dis. 2001 May 1;183(9):1343-52. Epub 2001 Apr 10.PMID: 11294665 [PubMed - indexed for MEDLINE]Related articles

    49.

    Cytokine responses to human immunodeficiency virus type 1 (HIV-1) induced by immunization with live recombinant canarypox virus vaccine expressing HIV-1 genes boosted by HIV-1(SF-2) recombinant GP120.

    Gorse GJ, Patel GB, Mandava MD, Arbuckle JA, Doyle TM, Belshe RB; National Institute of Allergy and Infectious Diseases AIDS Vaccine Evaluation Group.

    Vaccine. 2001 Feb 8;19(13-14):1806-19.PMID: 11166906 [PubMed - indexed for MEDLINE]Related articles

    50.

    Evaluation of a live, cold-passaged, temperature-sensitive, respiratory syncytial virus vaccine candidate in infancy.

    Wright PF, Karron RA, Belshe RB, Thompson J, Crowe JE Jr, Boyce TG, Halburnt LL, Reed GW, Whitehead SS, Anderson EL, Wittek AE, Casey R, Eichelberger M, Thumar B, Randolph VB, Udem SA, Chanock RM, Murphy BR.

    J Infect Dis. 2000 Nov;182(5):1331-42. Epub 2000 Sep 22.PMID: 11010838 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...